Abstract
In the conscious rat arterial PCO2 was measured as an index of respiratory status. The opioid analgesic meptazinol (7.5 - 30 mg kg-1) evoked small but significant increases in arterial PCO2 which were attenuated by naloxone. Meptazinol significantly reduced the increase in arterial PCO2 evoked by morphine. The respiratory depression induced by meptazinol, but not that induced by morphine, was enhanced by pretreatment with atropine. The (+)-enantiomer, but not the (-)-enantiomer of meptazinol increased arterial PCO2. In contrast, only the (-)-enantiomer reduced the respiratory depressant effect of morphine. It is proposed that the degree of respiratory depression induced by meptazinol is limited by its opioid antagonist and cholinomimetic properties.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bill D. J., Hartley J. E., Stephens R. J., Thompson A. M. The antinociceptive activity of meptazinol depends on both opiate and cholinergic mechanisms. Br J Pharmacol. 1983 May;79(1):191–199. doi: 10.1111/j.1476-5381.1983.tb10512.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duchesne R. J., Goodall J., Hughes I. E. Pharmacological effects of meptazinol and its enantiomers on guinea-pig ileum and mouse vas deferens. J Pharm Pharmacol. 1984 Aug;36(8):560–562. doi: 10.1111/j.2042-7158.1984.tb04455.x. [DOI] [PubMed] [Google Scholar]
- Goode P. G., Rhodes K. F., Waterfall J. F. The analgesic and respiratory effects of meptazinol, morphine and pentazocine in the rat. J Pharm Pharmacol. 1979 Nov;31(11):793–795. doi: 10.1111/j.2042-7158.1979.tb13664.x. [DOI] [PubMed] [Google Scholar]
- Goode P. G., Shite A. C., Green D. Some properties of WY 22811, a new analgesic compound. Br J Pharmacol. 1971 Oct;43(2):462P–463P. [PMC free article] [PubMed] [Google Scholar]
- Green D. Current concepts concerning the mode of action of meptazinol as an analgesic. Postgrad Med J. 1983;59 (Suppl 1):9–12. [PubMed] [Google Scholar]
- Jones J. G. The respiratory effects of meptazinol. Postgrad Med J. 1983;59 (Suppl 1):72–77. [PubMed] [Google Scholar]
- Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert P. E. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther. 1976 Jun;197(3):517–532. [PubMed] [Google Scholar]
- Pasternak G. W., Gintzler A. R., Houghten R. A., Ling G. S., Goodman R. R., Spiegel K., Nishimura S., Johnson N., Recht L. D. Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system. Life Sci. 1983;33 (Suppl 1):167–173. doi: 10.1016/0024-3205(83)90470-8. [DOI] [PubMed] [Google Scholar]
- Spiegel K., Pasternak G. W. Meptazinol: a novel Mu-1 selective opioid analgesic. J Pharmacol Exp Ther. 1984 Feb;228(2):414–419. [PubMed] [Google Scholar]
- Stephens R. J., Waterfall J. F., Franklin R. A. A review of the biological properties and metabolic disposition of the new analgesic agent, meptazinol. Gen Pharmacol. 1978;9(2):73–78. doi: 10.1016/0306-3623(78)90002-2. [DOI] [PubMed] [Google Scholar]
- Ward S. J., Takemori A. E. Determination of the relative involvement of mu-opioid receptors in opioid-induced depression of respiratory rate by use of beta-funaltrexamine. Eur J Pharmacol. 1983 Jan 28;87(1):1–6. doi: 10.1016/0014-2999(83)90043-2. [DOI] [PubMed] [Google Scholar]
- Weinstock M., Erez E., Roll D. Antagonism of the cardiovascular and respiratory depressant effects of morphine in the conscious rabbit by physostigmine. J Pharmacol Exp Ther. 1981 Aug;218(2):504–508. [PubMed] [Google Scholar]